The host-targeted antiviral drug Zapnometinib exhibits a high barrier to the development of SARS-CoV-2 resistance. Schreiber A; Rodner F; Oberberg N; Anhlan D; Bletz S; Mellmann A; Planz O; Ludwig S (2024) In: Antiviral Research, 225 Type of Publication: Research article (journal)
The Effector Domain of the Influenza A Virus Nonstructural Protein NS1 Triggers Host Shutoff by Mediating Inhibition and Global Deregulation of Host Transcription When Associated… Nacken, Wolfgang; Schreiber, André; Masemann, Dörthe; Ludwig, Stephan (2021) In: mBio, 12(5) Type of Publication: Research article (journal)

Dissertation Prize of the Faculty of Biology of the University of Münster
Awarded by: University of Münster
Award given to: Schreiber, Andre
Announced at: 10/11/2020 | Date of awarding: 15/12/2020
Type of distinction: Research award or other distinction